• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>ICO

ICO

  1. New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease

    New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.